MULTIPHARMA held to be similar to MUNDIPHARMA

European Union

The EU General Court has reversed the EU Intellectual Property Office First Board of Appeal’s judgment that there was no likelihood of confusion between the marks MUNDIPHARMA and MULTIPHARMA based on conceptual differences.

Unlock unlimited access to all WTR content